How to Use Mechanistic Metabolic Modeling to Ensure High Quality Glycoprotein Production

Glycosylation is one of the most important quality attributes directly affecting the activity of bio-therapeutics produced by cell culture technology. In our study, a metabolic model has been developed to find strategies to deal with the reduced sialylation of glycoforms which has an important role...

Full description

Saved in:
Bibliographic Details
Published inComputer Aided Chemical Engineering Vol. 40; pp. 2839 - 2844
Main Authors Ehsani, Alireza, Niedenfuehr, Sebastian, Eissing, Thomas, Behnken, Swantje, Schuppert, Andreas
Format Book Chapter
LanguageEnglish
Published 01.01.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Glycosylation is one of the most important quality attributes directly affecting the activity of bio-therapeutics produced by cell culture technology. In our study, a metabolic model has been developed to find strategies to deal with the reduced sialylation of glycoforms which has an important role in plasma half-life of glycoproteins. Our model is comprised of three major layers including a bioprocess model, as well as kinetic reaction networks representing cellular metabolism and glycosylation inside Golgi apparatus. The kinetic parameters were estimated performing a scatter search optimization. The estimated parameter set of the model is capable of reproducing glycoforms measured by in vitro experiments. In order to evaluate significance of different parts of the model, a global sensitivity analysis was conducted and the results were interpreted with respect to glycoform sialylation. This study thereby increases understanding of the formation of glycoforms and reveals complex interactions of different compartments within mammalian cells acting on the maturation of produced proteins of interest. The built model helps to clearly identify conditions for the bioprocess that ensure meeting the desired specifications of quality and, thus, make it more robust.
AbstractList Glycosylation is one of the most important quality attributes directly affecting the activity of bio-therapeutics produced by cell culture technology. In our study, a metabolic model has been developed to find strategies to deal with the reduced sialylation of glycoforms which has an important role in plasma half-life of glycoproteins. Our model is comprised of three major layers including a bioprocess model, as well as kinetic reaction networks representing cellular metabolism and glycosylation inside Golgi apparatus. The kinetic parameters were estimated performing a scatter search optimization. The estimated parameter set of the model is capable of reproducing glycoforms measured by in vitro experiments. In order to evaluate significance of different parts of the model, a global sensitivity analysis was conducted and the results were interpreted with respect to glycoform sialylation. This study thereby increases understanding of the formation of glycoforms and reveals complex interactions of different compartments within mammalian cells acting on the maturation of produced proteins of interest. The built model helps to clearly identify conditions for the bioprocess that ensure meeting the desired specifications of quality and, thus, make it more robust.
Author Niedenfuehr, Sebastian
Behnken, Swantje
Ehsani, Alireza
Eissing, Thomas
Schuppert, Andreas
Author_xml – sequence: 1
  givenname: Alireza
  surname: Ehsani
  fullname: Ehsani, Alireza
  organization: Bayer AG, 51368 Leverkusen, Germany
– sequence: 2
  givenname: Sebastian
  surname: Niedenfuehr
  fullname: Niedenfuehr, Sebastian
  organization: Bayer AG, 51368 Leverkusen, Germany
– sequence: 3
  givenname: Thomas
  surname: Eissing
  fullname: Eissing, Thomas
  organization: Bayer AG, 51368 Leverkusen, Germany
– sequence: 4
  givenname: Swantje
  surname: Behnken
  fullname: Behnken, Swantje
  organization: Bayer AG, 51368 Leverkusen, Germany
– sequence: 5
  givenname: Andreas
  surname: Schuppert
  fullname: Schuppert, Andreas
  email: schuppert@aices.rwth-aachen.de
  organization: Bayer AG, 51368 Leverkusen, Germany
BookMark eNotkFFLwzAUhQNOcM79h-J75k2TJs2jzrkJExUc7C10yc0WKY20mbJ_bzt9Oge-yz3wXZNRExsk5JbBjAGTdw9alRSoEIJKrmVB-awAoQq6vSDTnkFPzoCPyJgVCqjSQl6Radd9AkCeC51DOSbbVfzJUsw2HWYvaA9VE7oUbN9TtYv10KLDOjT74WrRdMcWs1XYH7L3Y1WHdMqW9cnGrzYmDE321kZ3tCnE5oZc-qrucPqfE7J5WnzMV3T9unye36-p5QwSzSUWPve-LIE5n3Pli6pCZ4UTrpS6xB2gRERtIddWKCeVF1prxpngSno-IY9_f7Ef-Q7Yms4GbCy60KJNxsVgGJhBmhmkGTC9GnN2Y7g5SzNb_gtOGWN1
CitedBy_id crossref_primary_10_1016_j_tibtech_2020_05_008
crossref_primary_10_1016_j_compchemeng_2020_107004
crossref_primary_10_1016_j_btre_2021_e00640
crossref_primary_10_1002_biot_201800573
ContentType Book Chapter
Copyright 2017 Elsevier B.V.
Copyright_xml – notice: 2017 Elsevier B.V.
DOI 10.1016/B978-0-444-63965-3.50475-X
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EndPage 2844
ExternalDocumentID B978044463965350475X
GroupedDBID -VX
20A
38.
AAAAS
AABBV
AAHFZ
AAJFB
AAKZG
AAORS
AAXUO
AAYWO
AAZNM
ABARN
ABGTF
ABGWT
ABJDO
ABLXK
ABMAC
ABMSR
ABNVE
ABQPQ
ABQQC
ABVHI
ACKCA
ACLGV
ADCEY
ADNDI
ADNKK
ADVEM
AEIOE
AEIUV
AEPKO
AERYV
AFNOJ
AFOJC
AIJLT
AJFER
AJLYV
AJMPQ
ALMA_UNASSIGNED_HOLDINGS
AQBRY
AUEHQ
AZZ
BAPMM
BBABE
BIOBC
BIQZX
BMNAY
BMYCL
BVXGA
CZZ
DKEWE
DUGUG
EBSCA
ECOWB
GEOUK
HGY
IOT
KQHZQ
MYL
SDK
XI1
ID FETCH-LOGICAL-c310t-26e5f2ff8801df237f5aaedc4d4d8698eb0e6eee9c029c47d67f49991314376f3
ISBN 9780444639653
0444639659
ISSN 1570-7946
IngestDate Fri Feb 23 02:26:17 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Glycosylation
Bioprocess optimization
Metabolic modeling
Mammalian cell culture
Glycoprotein
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c310t-26e5f2ff8801df237f5aaedc4d4d8698eb0e6eee9c029c47d67f49991314376f3
PageCount 6
ParticipantIDs elsevier_sciencedirect_doi_10_1016_B978_0_444_63965_3_50475_X
PublicationCentury 2000
PublicationDate 2017-01-01
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – month: 01
  year: 2017
  text: 2017-01-01
  day: 01
PublicationDecade 2010
PublicationTitle Computer Aided Chemical Engineering
PublicationYear 2017
SSID ssj0002249208
ssib045323371
Score 2.1039937
Snippet Glycosylation is one of the most important quality attributes directly affecting the activity of bio-therapeutics produced by cell culture technology. In our...
SourceID elsevier
SourceType Publisher
StartPage 2839
SubjectTerms Bioprocess optimization
Glycoprotein
Glycosylation
Mammalian cell culture
Metabolic modeling
Title How to Use Mechanistic Metabolic Modeling to Ensure High Quality Glycoprotein Production
URI https://dx.doi.org/10.1016/B978-0-444-63965-3.50475-X
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9wgEEWb9NLm0k_1Wxx6s0htg2F96CGpto0qNZdmJd8QNqBNGnmlxqsqued_dwDjZav00PZiWRaLMW92eIyYNwi9s1orq5UmFRUlYYJSojomiNWGKtgAzLl28Y6vp_xkyb40VTOb3SanljZDe9jd3JlX8i-owjPA1WXJ_gWyU6fwAO4BX7gCwnD9jfzuhlmDrsBYjyE7OtcuTBsz_xOFwYkur65C6abs6BJc3M3kik-BgJrebswqlN8ysKgNicEsAJax6Elyksin9az678FjffsJ4Fzs2J6vU7fOllfgM4xLLfZq0HA_gMk5VW1Xgc3nwUOrRe-ClP7ASRYUPa6zz5fX3dpLSJz3LpdBB43bNERRiCREEXeqTpYOyBAPysDR2YqcOIH71BsH8aboTudB6WhcmmEpZXe6_RCBOA5qwfAm4l9F6GGVM1GRZrvYTUcQj3cG5ds1e2hP1OAm7wElWExBH1bRkkbVwAuvGMTq0tc6nL7Aax2MndVR1yl2HrVuC_7-z0NMyFBCcM4eogOX9IJdNgoM_xGamf4xepCY0hPUAKp4WGNAFSeo4glVHFF1rQKq2KGKR1RxiireovoULT8tzj6ekLEuB-lgMzCQkpvKltaC6y-0LamwlVJGd0wzPef13LS54caYusvLGv74mgvrNtYFBXIuuKXP0H6_7s1zhJXoWG5YYSxs21suWl0o2_FSVVoJxfIX6EOcFTlSwkD1JEAv4wlFN6sylzCr0s-qpNLPqmxe_ufvX6H7W4N-jfaHHxvzBljo0L4dreQXBg19eQ
link.rule.ids 782,783,787,796,27939
linkProvider ProQuest Ebooks
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&rft.genre=bookitem&rft.title=Computer+Aided+Chemical+Engineering&rft.au=Ehsani%2C+Alireza&rft.au=Niedenfuehr%2C+Sebastian&rft.au=Eissing%2C+Thomas&rft.au=Behnken%2C+Swantje&rft.atitle=How+to+Use+Mechanistic+Metabolic+Modeling+to+Ensure+High+Quality+Glycoprotein+Production&rft.date=2017-01-01&rft.isbn=9780444639653&rft.issn=1570-7946&rft.volume=40&rft.spage=2839&rft.epage=2844&rft_id=info:doi/10.1016%2FB978-0-444-63965-3.50475-X&rft.externalDocID=B978044463965350475X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1570-7946&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1570-7946&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1570-7946&client=summon